Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 26 May 2009
Vol. 2, Issue 72, p. re3
[DOI: 10.1126/scisignal.272re3]
REVIEWS
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Roy L. Silverstein* and
Maria Febbraio
Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation and Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA.
Gloss: CD36 is a multifunctional cell-surface receptor present on many cell types, including platelets, mononuclear phagocytes, and muscle, fat, and gut cells. It is conserved in mammals, and there are many invertebrate orthologs. CD36 binds to several major classes of ligands, including the matrix protein thrombospondin, long-chain fatty acids, and oxidized phospholipids and lipoproteins; in different contexts, it serves to regulate angiogenesis, innate immune responses, fatty acid metabolism, and sensory responses to fatty acids. CD36 signaling is mediated by activation of specific intracellular pathways that may include kinases of the Src family and mitogen-activated protein kinases. Because of the importance of CD36 signaling in human diseases, including atherosclerosis, thrombosis, Alzheimers disease, obesity, diabetes, and cancer, these signaling pathways are under intense scrutiny. This Review includes two figures and 123 citations.
Citation: R. L. Silverstein, M. Febbraio, CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior. Sci. Signal.2, re3 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (23 August 2011) Sci. Signal.4 (187), ec235.
[DOI: 10.1126/scisignal.4187ec235] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD36 Mediates Endothelial Dysfunction Downstream of Circulating Factors Induced by O3 Exposure.
S. Robertson, E. S. Colombo, S. N. Lucas, P. R. Hall, M. Febbraio, M. L. Paffett, and M. J. Campen (2013)
Toxicol. Sci.
|Abstract »|Full Text »|PDF »
The Scavenger Receptor CD36 Downmodulates the Early Inflammatory Response while Enhancing Bacterial Phagocytosis during Pneumococcal Pneumonia.
O. Sharif, U. Matt, S. Saluzzo, K. Lakovits, I. Haslinger, T. Furtner, B. Doninger, and S. Knapp (2013)
J. Immunol.
190, 5640-5648
|Abstract »|Full Text »|PDF »
AICAR inhibits PPAR{gamma} during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
D. Namgaladze, M. Kemmerer, A. von Knethen, and B. Brune (2013)
Cardiovasc Res
98, 479-487
|Abstract »|Full Text »|PDF »
Sulfo-N-succinimidyl Oleate (SSO) Inhibits Fatty Acid Uptake and Signaling for Intracellular Calcium via Binding CD36 Lysine 164: SSO ALSO INHIBITS OXIDIZED LOW DENSITY LIPOPROTEIN UPTAKE BY MACROPHAGES.
O. Kuda, T. A. Pietka, Z. Demianova, E. Kudova, J. Cvacka, J. Kopecky, and N. A. Abumrad (2013)
J. Biol. Chem.
288, 15547-15555
|Abstract »|Full Text »|PDF »
Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis.
S. Meiler, Y. Baumer, Z. Huang, F. W. Hoffmann, G. J. Fredericks, A. H. Rose, R. L. Norton, P. R. Hoffmann, and W. A. Boisvert (2013)
J. Leukoc. Biol.
93, 771-780
|Abstract »|Full Text »|PDF »
Endothelial Fatty Acid Transport: Role of Vascular Endothelial Growth Factor B.
C. Hagberg, A. Mehlem, A. Falkevall, L. Muhl, and U. Eriksson (2013)
Physiology
28, 125-134
|Abstract »|Full Text »|PDF »
L. Park, J. Zhou, P. Zhou, R. Pistick, S. El Jamal, L. Younkin, J. Pierce, A. Arreguin, J. Anrather, S. G. Younkin, et al. (2013)
PNAS
110, 3089-3094
|Abstract »|Full Text »|PDF »
CD36 homolog divergence is responsible for the selectivity of carotenoid species migration to the silk gland of the silkworm Bombyx mori.
T. Sakudoh, S. Kuwazaki, T. Iizuka, J. Narukawa, K. Yamamoto, K. Uchino, H. Sezutsu, Y. Banno, and K. Tsuchida (2013)
J. Lipid Res.
54, 482-495
|Abstract »|Full Text »|PDF »
From Macrophage Interleukin-13 Receptor to Foam Cell Formation: MECHANISMS FOR {alpha}M{beta}2 INTEGRIN INTERFERENCE.
V. P. Yakubenko, L. C. Hsi, M. K. Cathcart, and A. Bhattacharjee (2013)
J. Biol. Chem.
288, 2778-2788
|Abstract »|Full Text »|PDF »
Brain and Circulating Levels of A{beta}1-40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain.
L. Park, P. Zhou, K. Koizumi, S. El Jamal, M. L. Previti, W. E. Van Nostrand, G. Carlson, and C. Iadecola (2013)
Stroke
44, 198-204
|Abstract »|Full Text »|PDF »
CD36 and Na/K-ATPase-{alpha}1 Form a Proinflammatory Signaling Loop in Kidney.
D. J. Kennedy, Y. Chen, W. Huang, J. Viterna, J. Liu, K. Westfall, J. Tian, D. J. Bartlett, W. H. W. Tang, Z. Xie, et al. (2013)
Hypertension
61, 216-224
|Abstract »|Full Text »|PDF »
CD36 level and trafficking are determinants of lipolysis in adipocytes.
D. Zhou, D. Samovski, A. L. Okunade, P. D. Stahl, N. A. Abumrad, and X. Su (2012)
FASEB J
26, 4733-4742
|Abstract »|Full Text »|PDF »
EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice.
V. L. Bessi, S. M. Labbe, D. N. Huynh, L. Menard, C. Jossart, M. Febbraio, B. Guerin, M. Bentourkia, R. Lecomte, A. C. Carpentier, et al. (2012)
Cardiovasc Res
96, 99-108
|Abstract »|Full Text »|PDF »
CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues.
R. A. DeFilippis, H. Chang, N. Dumont, J. T. Rabban, Y.-Y. Chen, G. V. Fontenay, H. K. Berman, M. L. Gauthier, J. Zhao, D. Hu, et al. (2012)
Cancer Discovery
2, 826-839
|Abstract »|Full Text »|PDF »
High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes.
X. Buque, A. Cano, M. E. Miquilena-Colina, C. Garcia-Monzon, B. Ochoa, and P. Aspichueta (2012)
Am J Physiol Endocrinol Metab
303, E504-E514
|Abstract »|Full Text »|PDF »
Thrombospondin-1 (TSP-1) Analogs ABT-510 and ABT-898 Inhibit Prolactinoma Growth and Recover Active Pituitary Transforming Growth Factor-{beta}1 (TGF-{beta}1).
M. V. Recouvreux, M. A. Camilletti, D. B. Rifkin, D. Becu-Villalobos, and G. Diaz-Torga (2012)
Endocrinology
153, 3861-3871
|Abstract »|Full Text »|PDF »
Oxidatively Modified Low Density Lipoprotein (LDL) Inhibits TLR2 and TLR4 Cytokine Responses in Human Monocytes but Not in Macrophages.
Y. Kannan, K. Sundaram, C. Aluganti Narasimhulu, S. Parthasarathy, and M. D. Wewers (2012)
J. Biol. Chem.
287, 23479-23488
|Abstract »|Full Text »|PDF »
CD36 Ectodomain Phosphorylation Blocks Thrombospondin-1 Binding: Structure-Function Relationships and Regulation by Protein Kinase C.
L.-Y. Chu and R. L. Silverstein (2012)
Arterioscler Thromb Vasc Biol
32, 760-767
|Abstract »|Full Text »|PDF »
Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo.
J. Fonager, E. M. Pasini, J. A. M. Braks, O. Klop, J. Ramesar, E. J. Remarque, I. O. C. M. Vroegrijk, S. G. van Duinen, A. W. Thomas, S. M. Khan, et al. (2012)
J. Exp. Med.
209, 93-107
|Abstract »|Full Text »|PDF »
Gene Expression in Livers of BALB/C and C57BL/6J Mice Fed a High-Fat Diet.
S. Nishikawa, J. Sugimoto, M. Okada, T. Sakairi, and S. Takagi (2012)
Toxicol Pathol
40, 71-82
|Abstract »|Full Text »|PDF »
Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data.
I. H. Bassyouni, T. A. Gheita, and R. M. Talaat (2011)
Rheumatology
50, 2108-2112
|Abstract »|Full Text »|PDF »
Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis.
T. T. T. Tran, H. Poirier, L. Clement, F. Nassir, M. M. A. L. Pelsers, V. Petit, P. Degrace, M.-C. Monnot, J. F. C. Glatz, N. A. Abumrad, et al. (2011)
J. Biol. Chem.
286, 25201-25210
|Abstract »|Full Text »|PDF »
Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.
A. Ghosh, G. Murugesan, K. Chen, L. Zhang, Q. Wang, M. Febbraio, R. M. Anselmo, K. Marchant, J. Barnard, and R. L. Silverstein (2011)
Blood
117, 6355-6366
|Abstract »|Full Text »|PDF »
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
B. Ren, J. Hale, S. Srikanthan, and R. L. Silverstein (2011)
Blood
117, 6036-6045
|Abstract »|Full Text »|PDF »
CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2.
O. Kuda, C. M. Jenkins, J. R. Skinner, S. H. Moon, X. Su, R. W. Gross, and N. A. Abumrad (2011)
J. Biol. Chem.
286, 17785-17795
|Abstract »|Full Text »|PDF »
Hematopoietic Cell-Restricted Deletion of CD36 Reduces High-Fat Diet-Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue.
H. T. Nicholls, G. Kowalski, D. J. Kennedy, S. Risis, L. A. Zaffino, N. Watson, P. Kanellakis, M. J. Watt, A. Bobik, A. Bonen, et al. (2011)
Diabetes
60, 1100-1110
|Abstract »|Full Text »|PDF »
S. O. Rahaman, W. Swat, M. Febbraio, and R. L. Silverstein (2011)
J. Biol. Chem.
286, 7010-7017
|Abstract »|Full Text »|PDF »
αM{beta}2 Integrin Activation Prevents Alternative Activation of Human and Murine Macrophages and Impedes Foam Cell Formation.
V. P. Yakubenko, A. Bhattacharjee, E. Pluskota, and M. K. Cathcart (2011)
Circ. Res.
108, 544-554
|Abstract »|Full Text »|PDF »
Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans.
S. Lecompte, F. Szabo de Edelenyi, L. Goumidi, G. Maiani, G. Moschonis, K. Widhalm, D. Molnar, A. Kafatos, A. Spinneker, C. Breidenassel, et al. (2011)
Am J Clin Nutr
93, 644-651
|Abstract »|Full Text »|PDF »
CD36: the common soil for inflammation in obesity and atherosclerosis?.
Z. Yang and X.-F. Ming (2011)
Cardiovasc Res
89, 485-486
|Full Text »|PDF »
Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria.
S. Das, K. A. Owen, K. T. Ly, D. Park, S. G. Black, J. M. Wilson, C. D. Sifri, K. S. Ravichandran, P. B. Ernst, and J. E. Casanova (2011)
PNAS
108, 2136-2141
|Abstract »|Full Text »|PDF »
Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.
L. Love-Gregory, R. Sherva, T. Schappe, J.-S. Qi, J. McCrea, S. Klein, M. A. Connelly, and N. A. Abumrad (2011)
Hum. Mol. Genet.
20, 193-201
|Abstract »|Full Text »|PDF »
Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance.
H. S. Kang, K. Okamoto, Y.-S. Kim, Y. Takeda, C. D. Bortner, H. Dang, T. Wada, W. Xie, X.-P. Yang, G. Liao, et al. (2011)
Diabetes
60, 177-188
|Abstract »|Full Text »|PDF »
The Evolution of Extracellular Matrix.
S. Ozbek, P. G. Balasubramanian, R. Chiquet-Ehrismann, R. P. Tucker, and J. C. Adams (2010)
Mol. Biol. Cell
21, 4300-4305
|Abstract »|Full Text »|PDF »
Oxidized Low-Density Lipoprotein and Atherosclerosis.
D. Steinberg and J. L. Witztum (2010)
Arterioscler Thromb Vasc Biol
30, 2311-2316
|Full Text »|PDF »
Regulation of Platelet Function by Class B Scavenger Receptors in Hyperlipidemia.
A. Zimman and E. A. Podrez (2010)
Arterioscler Thromb Vasc Biol
30, 2350-2356
|Abstract »|Full Text »|PDF »
Tlr2 is critical for diet-induced metabolic syndrome in a murine model.
Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand {beta}-glucocerebrosidase.
J. Blanz, J. Groth, C. Zachos, C. Wehling, P. Saftig, and M. Schwake (2010)
Hum. Mol. Genet.
19, 563-572
|Abstract »|Full Text »|PDF »